Atossa Therapeutics (ATOS) Gross Margin (2011 - 2015)
Atossa Therapeutics' Gross Margin came in at -119126.91% for Q4 2015, down 119226.91 percentage points from 100.00% a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Gross Margin (2011 - 2015) Analysis & Trends
For FY2015, Atossa Therapeutics' Gross Margin was -7431.91%, down 7531.91 percentage points from FY2014.
- Gross Margin carries a four-year change of -1052.58 percentage points (FY2011 to FY2015).
- Going back by year, Gross Margin was 100.00% in FY2014 (+78.33 pp), 21.67% in FY2013 (-64.71 pp), 86.38% in FY2012 (+6465.71 pp) and -6379.33% in FY2011.
- The Q4 2015 figure represents the lowest quarterly Gross Margin in data going back to Q4 2011.
- Year-over-year, Gross Margin increased in four of the last five quarters, with an average year-over-year change of -23741.07 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q4 2012 (a gain of 6473.48 percentage points), and the weakest in Q4 2015 (a drop of 119226.91 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -119,126.91% |
| Dec 31, 2014 | 100.00% |
| Sep 30, 2014 | 100.00% |
| Jun 30, 2014 | 100.00% |
| Mar 31, 2014 | 100.00% |
| Dec 31, 2013 | -283.16% |
| Sep 30, 2013 | 66.14% |
| Jun 30, 2013 | 31.87% |
| Mar 31, 2013 | 63.62% |
| Dec 31, 2012 | 94.15% |
| Sep 30, 2012 | 85.72% |
| Jun 30, 2012 | 92.03% |
| Mar 31, 2012 | 50.64% |
| Dec 31, 2011 | -6,379.33% |
API Access
Atossa Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();